SVEP1 and systemic lupus erythematosus: The principal findings of this study were as follows: 1) Among 35 pregnant women with SLE, 16 women (45.7%) developed APO; 2) Proteomic analysis of mid-trimester amniotic fluid showed different profiling pattern between the SLE patients without APO (Group 1) and the SLE patients with APO (Group 2); 3) The expression of FLNA, SVEP1, LCAT, and TGM2 was significantly increased in the SLE patients with APO (Group 2) compared with the SLE patients without APO (Group 1).